In particular, it will consider the issue of increasing Farmaco’s authorized capital through an additional issue of 703,200 shares with a nominal value of 37 lei each. Earlier, Farmaco’s authorized capital was increased by 7.3 million lei – up to 181 million lei.
It should be noted that this enterprise is one of the oldest drug manufacturers in Moldova: it started its activity in 1939 with the establishment of the chemical-pharmaceutical laboratory Farmaco. Until 1998, the plant was the only pharmaceutical manufacturer in Moldova. In the late 1990s, the state stake in Farmaco was sold to the Romanian-American company Europharm Inc., but in 2002 Farmaco returned to state ownership due to Europharm Inc’s failure to fulfill its stated investment obligations.
In 2014, Farmaco was privatized again, when the state stake of 94.6% for 51.5 million lei was acquired by the Swiss company Tauralp Pharm Holding AG. It later increased its stake in the authorized capital to 99%.
